Clinical trial / 2006
Hop extract reduced menopausal discomfort scores at six weeks but not twelve weeks
A 12-week trial evaluated hop extract standardized to 100 or 250 micrograms of 8-prenylnaringenin against placebo in 67 menopausal women. The 100-microgram dose reduced modified Kupperman index scores significantly more than placebo at six weeks (P = 0.023), but this difference was not maintained at 12 weeks (P = 0.086). Both doses significantly decreased hot flush scores at six weeks (P < 0.01), though the higher dose was less active overall.
- Study type
- Randomized controlled trial
- Who was studied
- 67 menopausal women
- What was measured
- Kupperman index and hot flush scores
THE PAPER
A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts.
Heyerick A, Vervarcke S, Depypere H, Bracke M, De Keukeleire D. Maturitas, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.